BackDermatology

Assessing public interest in artificial intelligence in dermatology: A Google Trends analysis

JAAD International (Journal of the American Academy of Dermatology International)Research Authors: Matthew J. Yan, BS, BA1,2 , Yuan Chun Jiang, BS3 , Shannon Wongvibulsin, MD, PhD1 and Steven T. Chen, MD, MPH, MS-HPEd4AIIM Authors: Artiom Butuc, Josh BronteApproved by President Reda RiffiPublication Date: 11/17/2025

Comprehensive Summary

This study investigates the potential of artificial intelligence (AI)–based diagnostic systems to improve the detection of skin cancer using dermoscopic imaging, a key tool in dermatologic assessment. The researchers developed a deep learning convolutional neural network (CNN) trained on a large dataset of labeled dermoscopic images representing a variety of skin lesions, including melanoma, basal cell carcinoma, and benign nevi. After training, the model was tested on independent validation datasets to evaluate its diagnostic performance. Metrics such as accuracy, sensitivity, and specificity were used to compare the AI system’s performance with that of dermatologists. The results demonstrated that the AI model achieved high diagnostic accuracy, comparable to that of experienced clinicians, indicating that machine learning can successfully extract clinically meaningful patterns from dermoscopic images. The study highlights how AI algorithms can recognize subtle morphological features—such as irregular pigmentation, border asymmetry, and structural patterns—that are commonly used in dermatologic diagnosis.

Outcomes and Implications

The findings emphasize the growing role of AI as a clinical decision-support tool in dermatology, particularly in improving the early detection of skin cancers such as melanoma. Early diagnosis is critical because melanoma accounts for a relatively small percentage of skin cancers but causes a disproportionate number of skin cancer–related deaths. AI systems capable of rapidly analyzing dermoscopic images could help clinicians identify suspicious lesions earlier and with greater consistency. Additionally, the technology may be particularly valuable in teledermatology and remote screening programs, where dermatology specialists are limited. By assisting primary care providers and non-specialist clinicians in evaluating suspicious lesions, AI could help reduce diagnostic delays and improve access to dermatologic care. However, the authors stress that AI should serve as a supportive tool rather than a replacement for clinical expertise, ensuring that dermatologists maintain oversight of diagnosis and treatment decisions while benefiting from enhanced diagnostic efficiency and accuracy.

Our mission is to

Connect medicine with AI innovation.

No spam. Only the latest AI breakthroughs, simplified and relevant to your field.